HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

X-inactivation in Fabry disease.

AbstractBACKGROUND:
Fabry disease is one of three X-linked lysosomal disorders. Because of X-chromosome inactivation (XCI), wherein there is (random) transcriptional silencing of one of the X-chromosomes in each female cell, females are mosaic for the expression of (some) X-linked genes. Thus, based on penetrance and expression, some females heterozygous for Fabry disease are symptomatic but not to the same degree as hemizygous males. The purpose of this study was to ascertain whether skewed X-inactivation favoring the mutant α-galactosidase A allele exists in our cohort of female heterozygotes of Fabry disease.
METHOD:
All patients were evaluated by physical examination and ascribed disease-specific severity sub-scores for each of the four categories (cardiac, renal, neurological, general) and a total score using the Mainz Severity Score Index (MSSI). Blood samples were drawn for enzymatic activity of α-galactosidase A and for DNA extraction for analysis for α-galactosidase A mutations. XCI ratios were determined from peripheral blood leukocyte samples. The X-chromosome inactivation ratio was determined in each heterozygote.
RESULTS:
Of 77 samples, only 18.2% were highly skewed (80/20). Only 14.3% of samples with nonsense mutations were highly skewed. There were no correlations between the XCI ratios and age, enzymatic activity of α-galactosidase A, MSSI sub-scores or total score, or with the clinical signs of cardiac involvement, neuropathic pain, or proteinuria.
CONCLUSION:
These findings are comparable with others in Fabry disease, i.e., essentially the same as seen in normal non-elderly female population, raising the question of the mechanism underlying symptomatic phenotypic expression in heterozygous females with Fabry disease.
AuthorsDeborah Elstein, Ella Schachamorov, Rachel Beeri, Gheona Altarescu
JournalGene (Gene) Vol. 505 Issue 2 Pg. 266-8 (Sep 01 2012) ISSN: 1879-0038 [Electronic] Netherlands
PMID22710134 (Publication Type: Journal Article)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • alpha-Galactosidase
Topics
  • Adult
  • Cohort Studies
  • Fabry Disease (enzymology, genetics)
  • Female
  • Humans
  • Kidney (enzymology)
  • Middle Aged
  • Mutation
  • Myocardium (enzymology)
  • Nervous System (enzymology)
  • Pain (enzymology, genetics)
  • Proteinuria (enzymology, genetics)
  • Severity of Illness Index
  • X Chromosome Inactivation (genetics)
  • alpha-Galactosidase (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: